Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01DHW
|
||||
| Former ID |
DNC014188
|
||||
| Drug Name |
9-O-[2-(Phenylol-1-yloxy)ethyl]berberine bromide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530625] | ||
| Formula |
C27H24BrNO5
|
||||
| Canonical SMILES |
COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCOC<br />6=CC=CC=C6.[Br-]
|
||||
| InChI |
1S/C27H24NO5.BrH/c1-29-24-8-7-18-13-23-21-15-26-25(32-17-33-26)14-19(21)9-10-28(23)16-22(18)27(24)31-12-11-30-20-5-3-2-4-6-20;/h2-8,13-16H,9-12,17H2,1H3;1H/q+1;/p-1
|
||||
| InChIKey |
PLHXLYBABFQCCA-UHFFFAOYSA-M
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [530625] | |
| Acetylcholinesterase | Target Info | Inhibitor | [530625] | ||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||